J. M. Llovet, A. Villanueva, A. Lachenmayer, and R. S. Finn, Advances in targeted therapies for hepatocellular carcinoma in the genomic era, Nat Rev Clin Oncol, vol.12, p.436, 2015.

D. Von-schweinitz, Hepatoblastoma: recent developments in research and treatment, Semin Pediatr Surg, vol.21, pp.21-30, 2012.

M. S. Grandhi, A. K. Kim, S. M. Ronnekleiv-kelly, I. R. Kamel, M. A. Ghasebeh et al., Hepatocellular carcinoma: From diagnosis to treatment, Surg Oncol, vol.25, pp.74-85, 2016.

D. L. Zynger, A. Gupta, C. Luan, P. M. Chou, G. Y. Yang et al., Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases, Hum Pathol, vol.39, pp.224-230, 2008.

M. I. Capurro, Y. Y. Xiang, C. Lobe, and J. Filmus, Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling, Cancer Res, vol.65, pp.6245-6254, 2005.

M. Capurro, T. Martin, W. Shi, and J. Filmus, Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling, J Cell Sci, vol.127, pp.1565-1575, 2014.

J. P. Lai, D. S. Sandhu, C. Yu, T. Han, C. D. Moser et al., Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma, Hepatology, vol.47, pp.1211-1222, 2008.

J. P. Lai, A. M. Oseini, C. D. Moser, C. Yu, S. F. Elsawa et al., The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation, Hepatology, vol.52, pp.1680-1689, 2010.

X. Zheng, X. Gai, S. Han, C. D. Moser, C. Hu et al., The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling, Genes Chromosomes Cancer, vol.52, pp.225-236, 2013.

Y. Hoshida, S. M. Nijman, M. Kobayashi, J. A. Chan, J. P. Brunet et al., Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma, Cancer Res, vol.69, pp.7385-7392, 2009.

M. Maurel, S. Jalvy, Y. Ladeiro, C. Combe, L. Vachet et al., A functional screening identifies five micrornas controlling glypican-3: role of mir-1271 down-regulation in hepatocellular carcinoma, Hepatology, vol.57, pp.195-204, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02437938

H. L. Miao, Z. J. Pan, C. J. Lei, J. Y. Wen, M. Y. Li et al., Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP, J Cell Biochem, vol.114, pp.625-631, 2013.

S. Jalvy-delvaille, M. Maurel, V. Majo, N. Pierre, S. Chabas et al., Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model, Nucleic Acids Res, vol.40, pp.1356-1365, 2012.

S. Jonas and E. Izaurralde, Towards a molecular understanding of microRNA-mediated gene silencing, Nat Rev Genet, vol.16, pp.421-433, 2015.

A. Helwak, G. Kudla, T. Dudnakova, and D. Tollervey, Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding, Cell, vol.153, pp.654-665, 2013.

M. Maurel, N. Dejeans, S. Taouji, E. Chevet, and C. F. Grosset, MicroRNA-1291-mediated silencing of IRE1alpha enhances Glypican-3 expression, RNA, vol.19, pp.778-788, 2013.

J. Hayes, P. P. Peruzzi, and S. Lawler, MicroRNAs in cancer: biomarkers, functions and therapy, Trends Mol Med, vol.20, pp.460-469, 2014.

Z. Li and T. M. Rana, Therapeutic targeting of microRNAs: current status and future challenges, Nat Rev Drug Discov, vol.13, pp.622-638, 2014.

E. Indersie, S. Lesjean, K. B. Hooks, F. Sagliocco, T. Ernault et al., MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting beta-catenin and Wnt signaling, Hepatol Comm, vol.1, pp.168-183, 2017.

I. Lee, S. S. Ajay, J. I. Yook, H. S. Kim, S. H. Hong et al., New class www.impactjournals.com/oncotarget of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites, Genome Res, vol.19, pp.1175-1183, 2009.

H. L. Miao, C. J. Lei, Z. D. Qiu, Z. K. Liu, R. Li et al., MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3, Hepatol Res, vol.44, pp.338-348, 2014.

N. Huang, J. Lin, J. Ruan, N. Su, R. Qing et al., MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3, FEBS Lett, vol.586, pp.884-891, 2012.

S. Boyault, D. S. Rickman, A. De-reynies, C. Balabaud, S. Rebouissou et al., Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets, Hepatology, vol.45, pp.42-52, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00130313

A. G. Bader, miR-34 -a microRNA replacement therapy is headed to the clinic, Frontiers in genetics, vol.3, p.120, 2012.

B. Laloo, M. Maurel, S. Jalvy-delvaille, F. Sagliocco, and C. F. Grosset, Analysis of post-transcriptional regulation using the FunREG method, Biochem Soc Trans, vol.38, pp.1608-1614, 2010.

B. Laloo, D. Simon, V. Veilla, D. Lauzel, V. Guyonnet-duperat et al., Analysis of post-transcriptional regulations by a functional, integrated, and quantitative method, Mol Cell Proteomics, vol.8, pp.1777-1788, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-02437946

E. Labbe, A. Letamendia, and L. Attisano, Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways, Proc Natl Acad Sci U S A, vol.97, pp.8358-8363, 2000.

S. P. Monga, beta-Catenin Signaling and Roles in Liver Homeostasis, Injury, and Tumorigenesis, Gastroenterology, vol.148, pp.1294-1310, 2015.

M. Hagedorn, S. Javerzat, D. Gilges, A. Meyre, B. De-lafarge et al., Accessing key steps of human tumor progression in vivo by using an avian embryo model, Proceedings of the National Academy of Sciences of the United States of America, vol.102, pp.1643-1648, 2005.

L. Dumartin, C. Quemener, H. Laklai, J. Herbert, R. Bicknell et al., Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells, Gastroenterology, vol.138, pp.1-8, 1606.
URL : https://hal.archives-ouvertes.fr/inserm-00505056

I. A. Asangani, B. Ateeq, Q. Cao, L. Dodson, M. Pandhi et al., Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer, Mol Cell, vol.49, pp.80-93, 2013.

W. Wei, L. Wanjun, S. Hui, C. Dongyue, Y. Xinjun et al., miR-203 inhibits proliferation of HCC cells by targeting survivin, Cell Biochem Funct, vol.31, pp.82-85, 2013.

E. Callegari, L. Gramantieri, M. Domenicali, D. 'abundo, L. Sabbioni et al., MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches, Cell Death Differ, vol.22, pp.46-57, 2015.

Y. X. Fang and W. Q. Gao, Roles of microRNAs during prostatic tumorigenesis and tumor progression, Oncogene, vol.33, pp.135-147, 2014.

F. J. Kohlhapp, A. K. Mitra, E. Lengyel, and M. E. Peter, MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment, Oncogene, vol.34, pp.5857-5868, 2015.

S. A. Ibrahim, H. Hassan, and M. Gotte, MicroRNA-dependent targeting of the extracellular matrix as a mechanism of regulating cell behavior, Biochim Biophys Acta, vol.1840, pp.2609-2620, 2014.

L. Li, J. R. Zhang, X. Lv, F. Liu, L. Liu et al., Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma, Hepatology, vol.56, pp.1380-1390, 2012.

J. H. Luo, B. Ren, S. Keryanov, G. C. Tseng, U. N. Rao et al., Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas, Hepatology, vol.44, pp.1012-1024, 2006.

X. Wu, X. Xu, S. Li, S. Wu, R. Chen et al., Identification and validation of potential biomarkers for the detection of dysregulated microRNA by qPCR in patients with colorectal adenocarcinoma, PLoS One, vol.10, p.120024, 2015.

D. Zhang, M. Kaneda, K. Nakahama, S. Arii, and I. Morita, Connexin 43 expression promotes malignancy of HuH7 hepatocellular carcinoma cells via the inhibition of cell-cell communication, Cancer Lett, vol.252, pp.208-215, 2007.

J. Kong, X. Zhou, S. Liu, J. T. Piao, Y. Liu et al., Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma, Int J Clin Exp Pathol, vol.7, pp.3018-3027, 2014.

T. Wei, L. N. Zhang, Y. Lv, X. Y. Ma, L. Zhi et al., Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indicates poor prognosis in hepatocellular carcinoma, Oncotarget, vol.5, pp.10307-10317, 2014.

J. K. Lam, M. Y. Chow, Y. Zhang, and S. W. Leung, siRNA Versus miRNA as Therapeutics for Gene Silencing, Mol Ther Nucleic Acids, vol.4, p.252, 2015.

A. D. Gonzalez, M. Kaya, W. Shi, H. Song, J. R. Testa et al., OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner, J Cell Biol, vol.141, pp.1407-1414, 1998.

V. Korinek, N. Barker, P. J. Morin, D. Van-wichen, R. De-weger et al., Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma, Science, vol.275, pp.1784-1787, 1997.